ScholarIQanswers from OpenAlex

Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype

PaperCitations, authors & open-access status

Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype have?

ScholarIQcitation count

Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype has 360 citations in the OpenAlex counts ScholarIQ stores.

When was Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype published?

ScholarIQyear

Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype has 2007 year in the ScholarIQ index.

What is the open-access status of Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype?

ScholarIQoa status

Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype has bronze oa status in the ScholarIQ index.

What is the DOI of Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype?

ScholarIQdoi

The DOI for Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype is on the source record.

What is the PMID of Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype?

ScholarIQpmid

The PMID for Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype is on the source record.

What is the OpenAlex record for Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype?

ScholarIQopenalex

The OpenAlex for Normocalcemic Primary Hyperparathyroidism: Further Characterization of a New Clinical Phenotype is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial